Tofacitinib treatment aggravates Staphylococcus aureus septic arthritis, but attenuates sepsis and enterotoxin induced shock in mice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tofacitinib treatment aggravates Staphylococcus aureus septic arthritis, but attenuates sepsis and enterotoxin induced shock in mice
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-02
DOI
10.1038/s41598-020-67928-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
- (2019) Nicholas A. Turner et al. NATURE REVIEWS MICROBIOLOGY
- Staphylococcus aureus bacteremia in patients with rheumatoid arthritis – Data from the prospective INSTINCT cohort
- (2017) Insa Joost et al. JOURNAL OF INFECTION
- The emerging safety profile of JAK inhibitors in rheumatic disease
- (2017) Kevin L. Winthrop Nature Reviews Rheumatology
- Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
- (2017) Philip Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiological features of experimental staphylococcal septic arthritis by micro computed tomography scan
- (2017) Farah Fatima et al. PLoS One
- Immunotherapy of Sepsis: Blind Alley or Call for Personalized Assessment?
- (2016) Miroslav Prucha et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Deficiency of the Complement Component 3 but Not Factor B Aggravates Staphylococcus aureus Septic Arthritis in Mice
- (2016) Manli Na et al. INFECTION AND IMMUNITY
- Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis
- (2015) A Richter et al. ANNALS OF THE RHEUMATIC DISEASES
- CTLA4 Immunoglobulin but Not Anti–Tumor Necrosis Factor Therapy Promotes Staphylococcal Septic Arthritis in Mice
- (2015) Abukar Ali et al. JOURNAL OF INFECTIOUS DISEASES
- Type I/II cytokines, JAKs and new strategies for treating autoimmune diseases
- (2015) Daniella M. Schwartz et al. Nature Reviews Rheumatology
- IL-1 Receptor Antagonist Treatment Aggravates Staphylococcal Septic Arthritis and Sepsis in Mice
- (2015) Abukar Ali et al. PLoS One
- Tofacitinib versus Methotrexate in Rheumatoid Arthritis
- (2014) Eun Bong Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of bloodstream infection: a review of population-based studies
- (2013) K.B. Laupland CLINICAL MICROBIOLOGY AND INFECTION
- Reduction of Immunocompetent T Cells Followed by Prolonged Lymphopenia in Severe Sepsis in the Elderly*
- (2013) Shigeaki Inoue et al. CRITICAL CARE MEDICINE
- Predictors of Mortality in Staphylococcus aureus Bacteremia
- (2012) S. J. van Hal et al. CLINICAL MICROBIOLOGY REVIEWS
- Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
- (2012) Ronald F. van Vollenhoven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register
- (2011) J. B. Galloway et al. ANNALS OF THE RHEUMATIC DISEASES
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- The Combination of a Tumor Necrosis Factor Inhibitor and Antibiotic Alleviates Staphylococcal Arthritis and Sepsis in Mice
- (2011) Ying Fei et al. JOURNAL OF INFECTIOUS DISEASES
- JAK2 inhibition prevents innate immune responses and rescues animals from sepsis
- (2010) Geber Peña et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Bacterial septic arthritis in adults
- (2010) Catherine J Mathews et al. LANCET
- Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis
- (2010) Marcin Kłak et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Gram-positive toxic shock syndromes
- (2009) Emma Lappin et al. LANCET INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started